Partners
We operate within an industrial and academic partnership ecosystem covering the entire development chain.
Probiomics is an innovative spin-off from the University of Rome Tor Vergata, specializing in the analysis of biological complexity across multiple OMIC levels, including proteomics, RNA sequencing, DNA sequencing, and gene expression in purified cell subsets. Utilizing validated methodologies, the platform offers robust bioinformatics pipelines, deep learning applications, and advanced data interpretation to address complex scientific challenges.
LenioBio GmbH is a biotechnology company pioneering cell-free protein expression through its ALiCE® platform. This innovative technology enables rapid discovery, development, and scalable production of complex proteins that are difficult or impossible to produce in living cells, supporting breakthroughs in research, therapeutics, and industrial applications.